Latest filing published 08 Sept 2022 for Relay Therapeutics, Inc., €748k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -14.5%Entry US$40.04 · Close at T+365 US$34.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark Murcko: trading record in brief
Mark Murcko appears in our data through filings on Relay Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 20 July 2020 to 8 September 2022.
Market trades split into 1 purchase (€436k) and 1 sale (€748k). On balance, insiders were net sellers of €312k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2022 alone, the filings show no purchases and 1 sale.
The latest filing, published on 8 September 2022, reports an open-market sale of €748k in Relay Therapeutics, Inc. The last insider purchase was made public on 21 July 2020, 2,302 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Murcko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$29.95100.0% of flowCommon StockSEC:0001209191-22-049246:0
- 25,000 shares@ US$20.0036.8% of flowCommon StockSEC:0000899243-20-019846:2Canonical exit: 18 Oct 2020 (T+90)
- 281,617 sharesCommon StockSEC:0000899243-20-019846:0
- 278,829 sharesCommon StockSEC:0000899243-20-019846:1
4 of 4 declarations
